KLTO
Price:
$0.49
Market Cap:
$25.82M
Klotho Neurosciences, Inc., a biopharmaceutical company, develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates include AMI-101 for the treatment or prevention of Alzheimer's disease; and AMI-202 to treat and prevent amyotrophic lateral sclerosis. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. The company is based in Omaha, Nebraska.
Industry
Biotechnology
IPO Date
2022-04-29
Stock Exchange
NASDAQ
Ticker
KLTO
According to Klotho Neurosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 83.69. This represents a change of 52.26% compared to the average of 54.96 of the last 4 quarters.
The mean historical Current Ratio of Klotho Neurosciences, Inc. over the last ten years is 4.10. The current 83.69 Current Ratio has changed 204.08% with respect to the historical average. Over the past ten years (40 quarters), KLTO's Current Ratio was at its highest in in the June 2025 quarter at 135.74. The Current Ratio was at its lowest in in the June 2022 quarter at 0.
Average
4.10
Median
0.13
Minimum
0
Maximum
20.12
Discovering the peaks and valleys of Klotho Neurosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Current Ratio = 20.12
Minimum Annual Increase = -98.80%
Minimum Annual Current Ratio = 0
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0.13 | 2.98% |
| 2023 | 0.00 | -98.31% |
| 2022 | 0.24 | -98.80% |
| 2021 | 20.12 | Infinity% |
The current Current Ratio of Klotho Neurosciences, Inc. (KLTO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
0.12
5-year avg
4.10
10-year avg
4.10
Klotho Neurosciences, Inc.’s Current Ratio is greater than Cadrenal Therapeutics, Inc. Common Stock (3.02), greater than Rallybio Corporation (9.98), greater than Exicure, Inc. (1.89), greater than Minerva Neurosciences, Inc. (6.15), greater than iBio, Inc. (8.39), greater than NeuroSense Therapeutics Ltd. (0.71), greater than Sonnet BioTherapeutics Holdings, Inc. (0.26), greater than TAO Synergies Inc. (20.51), greater than MetaVia Inc. (2.08), greater than NeurAxis, Inc. (1.58),
| Company | Current Ratio | Market cap |
|---|---|---|
| 3.02 | $23.04M | |
| 9.98 | $28.16M | |
| 1.89 | $42.96M | |
| 6.15 | $26.16M | |
| 8.39 | $21.16M | |
| 0.71 | $29.60M | |
| 0.26 | $8.43M | |
| 20.51 | $23.26M | |
| 2.08 | $16.10M | |
| 1.58 | $28.86M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Klotho Neurosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Klotho Neurosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Klotho Neurosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Klotho Neurosciences, Inc. (KLTO)?
What is the highest Current Ratio for Klotho Neurosciences, Inc. (KLTO)?
What is the 3-year average Current Ratio for Klotho Neurosciences, Inc. (KLTO)?
What is the 5-year average Current Ratio for Klotho Neurosciences, Inc. (KLTO)?
How does the current Current Ratio for Klotho Neurosciences, Inc. (KLTO) compare to its historical average?